Logo image of ALGEV.PA

GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALGEV - FR0000033888 - Common Stock

178 EUR
+6 (+3.49%)
Last: 1/12/2026, 7:00:00 PM
Fundamental Rating

4

Overall ALGEV gets a fundamental rating of 4 out of 10. We evaluated ALGEV against 114 industry peers in the Machinery industry. While ALGEV has a great health rating, there are worries on its profitability. ALGEV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALGEV had positive earnings in the past year.
ALGEV had a positive operating cash flow in the past year.
Each year in the past 5 years ALGEV has been profitable.
ALGEV had a positive operating cash flow in 4 of the past 5 years.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.13%, ALGEV is doing worse than 72.81% of the companies in the same industry.
ALGEV has a worse Return On Equity (0.16%) than 71.93% of its industry peers.
With a Return On Invested Capital value of 0.48%, ALGEV is not doing good in the industry: 80.70% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for ALGEV is significantly below the industry average of 9.14%.
Industry RankSector Rank
ROA 0.13%
ROE 0.16%
ROIC 0.48%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

Looking at the Profit Margin, with a value of 0.23%, ALGEV is doing worse than 72.81% of the companies in the same industry.
ALGEV's Profit Margin has declined in the last couple of years.
The Operating Margin of ALGEV (0.97%) is worse than 81.58% of its industry peers.
In the last couple of years the Operating Margin of ALGEV has declined.
With an excellent Gross Margin value of 59.17%, ALGEV belongs to the best of the industry, outperforming 81.58% of the companies in the same industry.
In the last couple of years the Gross Margin of ALGEV has remained more or less at the same level.
Industry RankSector Rank
OM 0.97%
PM (TTM) 0.23%
GM 59.17%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALGEV is destroying value.
Compared to 1 year ago, ALGEV has less shares outstanding
Compared to 5 years ago, ALGEV has less shares outstanding
Compared to 1 year ago, ALGEV has a worse debt to assets ratio.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.68 indicates that ALGEV is not in any danger for bankruptcy at the moment.
ALGEV has a better Altman-Z score (3.68) than 78.07% of its industry peers.
ALGEV has a debt to FCF ratio of 2.95. This is a good value and a sign of high solvency as ALGEV would need 2.95 years to pay back of all of its debts.
ALGEV has a better Debt to FCF ratio (2.95) than 71.93% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that ALGEV is not too dependend on debt financing.
ALGEV has a better Debt to Equity ratio (0.04) than 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.95
Altman-Z 3.68
ROIC/WACC0.06
WACC7.85%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ALGEV has a Current Ratio of 5.07. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
ALGEV has a Current ratio of 5.07. This is amongst the best in the industry. ALGEV outperforms 97.37% of its industry peers.
A Quick Ratio of 3.68 indicates that ALGEV has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.68, ALGEV belongs to the best of the industry, outperforming 97.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.07
Quick Ratio 3.68
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

The earnings per share for ALGEV have decreased strongly by -96.89% in the last year.
ALGEV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.19% yearly.
Looking at the last year, ALGEV shows a small growth in Revenue. The Revenue has grown by 2.81% in the last year.
The Revenue has been growing slightly by 5.90% on average over the past years.
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 395.56, the valuation of ALGEV can be described as expensive.
ALGEV's Price/Earnings ratio is a bit more expensive when compared to the industry. ALGEV is more expensive than 73.68% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.25. ALGEV is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 13.15, ALGEV is valued correctly.
Based on the Price/Forward Earnings ratio, ALGEV is valued a bit cheaper than 66.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALGEV to the average of the S&P500 Index (23.98), we can say ALGEV is valued slightly cheaper.
Industry RankSector Rank
PE 395.56
Fwd PE 13.15
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

ALGEV's Enterprise Value to EBITDA is on the same level as the industry average.
ALGEV's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. ALGEV is more expensive than 67.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 41.05
EV/EBITDA 12.87
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALGEV does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)111.49
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

ALGEV has a Yearly Dividend Yield of 2.78%. Purely for dividend investing, there may be better candidates out there.
ALGEV's Dividend Yield is rather good when compared to the industry average which is at 1.55. ALGEV pays more dividend than 86.84% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.92, ALGEV pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

The dividend of ALGEV is nicely growing with an annual growth rate of 21.15%!
Dividend Growth(5Y)21.15%
Div Incr Years4
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

1132.65% of the earnings are spent on dividend by ALGEV. This is not a sustainable payout ratio.
The dividend of ALGEV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP1132.65%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

GEVELOT SA

EPA:ALGEV (1/12/2026, 7:00:00 PM)

178

+6 (+3.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-30 2025-10-30
Earnings (Next)04-30 2026-04-30
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap133.50M
Revenue(TTM)148.53M
Net Income(TTM)340.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP1132.65%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 395.56
Fwd PE 13.15
P/S 0.9
P/FCF 41.05
P/OCF 16.94
P/B 0.63
P/tB 0.64
EV/EBITDA 12.87
EPS(TTM)0.45
EY0.25%
EPS(NY)13.53
Fwd EY7.6%
FCF(TTM)4.34
FCFY2.44%
OCF(TTM)10.51
OCFY5.9%
SpS198.04
BVpS281.9
TBVpS277.87
PEG (NY)111.49
PEG (5Y)N/A
Graham Number53.42
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 0.16%
ROCE 0.64%
ROIC 0.48%
ROICexc 0.57%
ROICexgc 0.58%
OM 0.97%
PM (TTM) 0.23%
GM 59.17%
FCFM 2.19%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexgc growth 3Y-45.56%
ROICexgc growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.95
Debt/EBITDA 0.99
Cap/Depr 66.07%
Cap/Sales 3.12%
Interest Coverage 250
Cash Conversion 93.23%
Profit Quality 956.47%
Current Ratio 5.07
Quick Ratio 3.68
Altman-Z 3.68
F-Score5
WACC7.85%
ROIC/WACC0.06
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.81%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y140.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y261.56%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%

GEVELOT SA / ALGEV.PA FAQ

What is the ChartMill fundamental rating of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGEV.PA.


What is the valuation status for ALGEV stock?

ChartMill assigns a valuation rating of 2 / 10 to GEVELOT SA (ALGEV.PA). This can be considered as Overvalued.


What is the profitability of ALGEV stock?

GEVELOT SA (ALGEV.PA) has a profitability rating of 3 / 10.


What is the valuation of GEVELOT SA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for GEVELOT SA (ALGEV.PA) is 395.56 and the Price/Book (PB) ratio is 0.63.


How sustainable is the dividend of GEVELOT SA (ALGEV.PA) stock?

The dividend rating of GEVELOT SA (ALGEV.PA) is 4 / 10 and the dividend payout ratio is 1132.65%.